Print Page  Close Window

2019 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009
DateTitle 
04/18/19Quest Diagnostics Launches New Consumer-Initiated STD Tests Through QuestDirect™
Available nationwide, the new services link consumer-initiated testing with medical oversight and counsel to help combat the nation's record rate of STDs SECAUCUS, N.J., April 18, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States. The new STD test pac... 
Printer Friendly Version
04/11/19Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis
Analysis of more than ten million workplace drug test results shows increases in marijuana positivity across nearly all employee testing categories Increases in post-accident positivity in the general U.S. workforce outpace those for all other testing reasons, including pre-employment screening SECAUCUS, N.J., April 11, 2019 /PRNewswire/ -- The rate of workforce drug positivity hit a fourteen-year high in 2018, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), th... 
Printer Friendly Version
04/04/19Quest Diagnostics To Release First Quarter 2019 Financial Results On April 23
SECAUCUS, N.J., April 4, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2019 results on Tuesday, April 23, 2019, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed by dialing 888-455-0391 within the U.S. and Ca... 
Printer Friendly Version
04/03/19Quest Diagnostics Presents Supplier Excellence Awards to Four Partners
SECAUCUS, N.J., April 3, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence awards to four companies at its 2019 Supplier Forum. Supplier Excellence awards recognize world-class products, systems, or services that provide consistent and reliable performance; companies that develop and implement novel solutions to move the business forward; individuals who step up... 
Printer Friendly Version
04/01/19Quest Diagnostics Achieves Perfect Score On 2019 Human Rights Campaign Corporate Equality Index for Third Consecutive Year
SECAUCUS, N.J., April 1, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human Rights Campaign Foundation on the 2019 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBTQ Equality."  The Corporate Equality Index (CEI) is a national benchmarking survey and report on corporate policies and practices relat... 
Printer Friendly Version
04/01/19Massachusetts Governor Baker Visits State of the Art Quest Diagnostics Marlborough Laboratory
MARLBOROUGH, Mass., April 1, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, hosted Massachusetts Governor Charlie Baker at its state-of-the-art clinical testing laboratory in Marlborough, Massachusetts on Friday, March 29.  During the visit Governor Baker toured the laboratory, met with employees, and learned more about the company's initiatives in the areas of pricing transparency, Alzheime... 
Printer Friendly Version
03/26/19Quest Diagnostics to Present New Insights from Genetic Testing at the 2019 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
Eight presentations highlight Quest's Advanced Diagnostics testing and research insights into hereditary genetics SECAUCUS, N.J., March 26, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of eight studies at the 2019 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, to be held April 2 – 6, 2019 in Seattle, Wash. (Quest Diagnostics booth 929... 
Printer Friendly Version
03/07/19Quest Diagnostics Prices $500 Million of Senior Notes
SECAUCUS, N.J., March 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $500 million aggregate principal amount of its 4.200% senior notes due 2029 under the Quest Diagnostics' shelf registration statement. Quest Diagnostics expects to receive the net offering proceeds upon closing on March 12, 2019, subject to customary closing... 
Printer Friendly Version
03/07/19Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
SECAUCUS, N.J., March 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami.  Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, March 12, 2019 at 10:15 a.m. Eastern Time... 
Printer Friendly Version
03/01/19Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., March 1, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on April 22, 2019 to shareholders of record of Quest Diagnostics common stock on April 8, 2019. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the w... 
Printer Friendly Version
02/27/19RMC and Quest Diagnostics to Deliver High-Value, Innovative Lab Services
SECAUCUS, N.J. and ORANGEBURG, S.C., Feb. 27, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center (RMC) of Orangeburg, S.C., are teaming up to enhance the quality and value of diagnostic services for patients and their doctors through a new partnership agreement under which Quest will provide full laboratory management services.  "We are very pleased to partner with RM... 
Printer Friendly Version
02/20/19Quest Diagnostics Partners With Houston Healthcare to Deliver High-Value, Innovative Laboratory Services
SECAUCUS, N.J. and WARNER ROBINS, Ga., Feb. 20, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide full laboratory management services for Houston Medical Center and Perry Hospital. "We are pleased to partner... 
Printer Friendly Version
02/19/19Quest Diagnostics Elects Denise Morrison to Board of Directors
SECAUCUS, N.J., Feb. 19, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Denise M. Morrison to serve as a director, effective February 18, 2019.  Including Ms. Morrison, the company's Board has 11 members. Ms. Morrison served as President and Chief Executive Officer of Campbell Soup Company from 2011 to 2018. "In addition to her broad m... 
Printer Friendly Version
02/18/19Quest Diagnostics Names Gabrielle Wolfson Senior Vice President and Chief Information and Digital Officer
SECAUCUS, N.J., Feb. 18, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Gabrielle Wolfson, a veteran information technology business leader, has been named Senior Vice President and Chief Information and Digital Officer. She reports directly to Steve Rusckowski, Chairman, President and CEO, and is based at the company's headquarters in Secaucus, N.J. Ms. Wolfson is res... 
Printer Friendly Version
02/14/19Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019
- Fourth quarter revenues of $1.84 billion, down 1.4% versus 2017 - Fourth quarter diluted EPS of $0.92 on a reported basis, down 49.5% from 2017 which included a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.36 on an adjusted basis excluding amortization, down 2.9% from 2017 - Full year revenues of $7.53 billion, up 1.7% from 2017 - Full year diluted EPS of $5.29 on a reported basis, down 3.8% from 2017; and $6.31 on an adjusted basis excluding amortizati... 
Printer Friendly Version
02/11/19Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories
Transaction expands access to diagnostic innovations in clinical and pathology services for patients, physicians and hospitals throughout Missouri and surrounding Midwestern states SECAUCUS, N.J. and COLUMBIA, Mo., Feb. 11, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Labor... 
Printer Friendly Version
01/22/19Quest Diagnostics Named One of 2019 "World's Most Admired Companies" by Fortune Magazine for Fourth Consecutive Year
SECAUCUS, N.J., Jan. 22, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year.  The annual survey designated Quest Diagnostics as one of only five companies to attain Most Admired status in the "Health Care: Pharmacy and Other Services" industry category.  "We are h... 
Printer Friendly Version
01/14/19More Adults Know Their Multidigit Wi-Fi Password Than Vital Health Information, Including Their Single-Letter Blood Type
Nearly Six in Ten Recognize Access to Health Vitals is Important in an Emergency, Yet Nearly 30 Percent Keep Lab Results in a File Cabinet at Home Challenges Retaining and Accessing Key Medical Information are Key Drivers to This Lack of Knowledge SECAUCUS, N.J., Jan. 14, 2019 /PRNewswire/ -- Americans have multiple numbers at their fingertips, but some of the numbers that could be most important to their health are not among them. New research released today by Quest Diagnostics (NYSE: DG... 
Printer Friendly Version
01/07/19Quest Diagnostics To Release Fourth Quarter And Full Year 2018 Financial Results On February 14
SECAUCUS, N.J., Jan. 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2018 results on Thursday, February 14, 2019, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed by dialing 888-455-0391 with... 
Printer Friendly Version
01/02/19Quest Diagnostics To Speak At The 37th Annual J.P. Morgan Healthcare Conference
SECAUCUS, N.J., Jan. 2, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference in San Francisco.  Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation... 
Printer Friendly Version